Home
OGEN
OGEN News

Latest Oragenics Inc. (OGEN) News on September 18, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

GlobeNewswire

3 months ago

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

MT Newswires

3 months ago

Top Premarket Decliners

Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split

GlobeNewswire

4 months ago

Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

GlobeNewswire

4 months ago

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia

Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision

GlobeNewswire

4 months ago

Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision

Associated Press Finance

4 months ago

Oragenics: Q1 Earnings Snapshot

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

GlobeNewswire

5 months ago

Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

GlobeNewswire

5 months ago

Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

GlobeNewswire

5 months ago

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

GlobeNewswire

6 months ago

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K

GlobeNewswire

6 months ago

Oragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K

Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI)

GlobeNewswire

6 months ago

Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI)

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment

GlobeNewswire

7 months ago

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment

Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health

GlobeNewswire

7 months ago

Oragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health

Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

GlobeNewswire

7 months ago

Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025

GlobeNewswire

7 months ago

Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025

Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO

GlobeNewswire

8 months ago

Oragenics, Inc. Provides Shareholder Update on Strategic Progress and Announces Janet Huffman as Interim CEO

Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference

GlobeNewswire

9 months ago

Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

GlobeNewswire

a year ago

Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

GlobeNewswire

a year ago

Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

GlobeNewswire

a year ago

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate

Benzinga

a year ago

EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate

Oragenics, Inc. Announces Closing of Public Offering

GlobeNewswire

a year ago

Oragenics, Inc. Announces Closing of Public Offering

MT Newswires

a year ago

Top Midday Decliners

MT Newswires

a year ago

Oragenics Stock Falls After Public Offering Priced to Raise $4.45 Million

Oragenics, Inc. Announces Pricing of Public Offering

GlobeNewswire

a year ago

Oragenics, Inc. Announces Pricing of Public Offering

MT Newswires

a year ago

Oragenics Completes Spray-Dried Formulation for Concussion Treatment Candidate

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

GlobeNewswire

a year ago

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients

Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards

GlobeNewswire

a year ago

Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

GlobeNewswire

a year ago

Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range

MT Newswires

a year ago

Oragenics Shares Rise After Study Shows No DNA Damage From Concussion Drug Candidate

Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study

GlobeNewswire

a year ago

Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study

Associated Press Finance

a year ago

Oragenics: Q2 Earnings Snapshot

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

GlobeNewswire

a year ago

Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity Testing

EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase II Trials Underway

Benzinga

a year ago

EXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase II Trials Underway

Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients

GlobeNewswire

a year ago

Oragenics Improves Intranasal Drug Formulation for Treating Concussed Patients

Oragenics Develops Automated Intranasal Device for Treating Concussed Patients

GlobeNewswire

a year ago

Oragenics Develops Automated Intranasal Device for Treating Concussed Patients

Oragenics, Inc. Announces Closing of Public Offering

GlobeNewswire

a year ago

Oragenics, Inc. Announces Closing of Public Offering

MT Newswires

a year ago

Top Midday Decliners

Oragenics, Inc. Announces Pricing of Public Offering

GlobeNewswire

a year ago

Oragenics, Inc. Announces Pricing of Public Offering

Oragenics, Inc. Announces Proposed Public Offering

GlobeNewswire

a year ago

Oragenics, Inc. Announces Proposed Public Offering

Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance

GlobeNewswire

a year ago

Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance

Journal-News, Hamilton, Ohio

a year ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

TechCrunch

a year ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Motley Fool

a year ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Bloomberg

a year ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Start Proud Opens the Market

CNW Group

a year ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Associated Press Finance

a year ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

Business Wire

a year ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

Investor's Business Daily

a year ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary

Yahoo Finance Video

a year ago

May jobs reports signals Fed's soft landing: US Labor Secretary

Notification of major holding in Kindred Group plc

PR Newswire

a year ago

Notification of major holding in Kindred Group plc

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

Business Wire

a year ago

Form 8.3 - DS Smith plc

Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer

GlobeNewswire

a year ago

Oragenics Appoints William “Frank” Peacock MD as Chief Clinical Officer

Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

GlobeNewswire

a year ago

Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

MT Newswires

a year ago

Oragenics to Start Phase 2 Concussion Treatment Drug Trial -- Shares Rise

Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial

GlobeNewswire

a year ago

Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial

Associated Press Finance

a year ago

Oragenics: Q1 Earnings Snapshot

Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia

GlobeNewswire

a year ago

Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia

Business Wire

a year ago

Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Business Wire

a year ago

Oragenics, Inc. Files 10K and Provides Company Update

Business Wire

2 years ago

Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion

15 Highest Quality Probiotics For Gut Health

Insider Monkey

2 years ago

15 Highest Quality Probiotics For Gut Health

Business Wire

2 years ago

Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion

Business Wire

2 years ago

Oragenics Announces Closing of Public Offering

Business Wire

2 years ago

Oragenics Announces Pricing of Public Offering

Business Wire

2 years ago

Oragenics Announces Proposed Public Offering

Business Wire

2 years ago

Oragenics, Inc. Announces Leadership Transition

Business Wire

2 years ago

Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement

Business Wire

2 years ago

Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion

Business Wire

2 years ago

Oragenics Announces Termination of At-The-Market Offering Program

Silynxcom Receives $400,000 Follow Up Order from a Leading Global Defense Company

GlobeNewswire

2 years ago

Silynxcom Receives $400,000 Follow Up Order from a Leading Global Defense Company

The 3 Most Undervalued AI Stocks to Buy in January

InvestorPlace

2 years ago

The 3 Most Undervalued AI Stocks to Buy in January

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

Zacks

2 years ago

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

GlobeNewswire

2 years ago

Guardforce AI Appoints Yuting Zuo as Chief Financial Officer

Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

GlobeNewswire

2 years ago

Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Comstock Acquires and Retires Over 2.6 Million Common Shares

GlobeNewswire

2 years ago

Comstock Acquires and Retires Over 2.6 Million Common Shares

3 Meme Stocks to Sell in January Before They Crash and Burn

InvestorPlace

2 years ago

3 Meme Stocks to Sell in January Before They Crash and Burn

Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down

Zacks

2 years ago

Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down

3 Meme Stocks That Are About to Get Absolutely Crushed

InvestorPlace

2 years ago

3 Meme Stocks That Are About to Get Absolutely Crushed

KULR to Introduce KULR ONE MAX at CES 2024

GlobeNewswire

2 years ago

KULR to Introduce KULR ONE MAX at CES 2024

Business Wire

2 years ago

Oragenics Completes Acquisition of Odyssey Health’s Neurological Assets

GlobeNewswire

2 years ago

Quipt Home Medical Corp. Announces Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus

LE Worldwide Limited Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign

Newsfile

2 years ago

LE Worldwide Limited Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign

Workhorse Group Receives First Fleet Order for W56 Step Van

GlobeNewswire

2 years ago

Workhorse Group Receives First Fleet Order for W56 Step Van

Bear of the Day: America's Car-Mart (CRMT)

Zacks

2 years ago

Bear of the Day: America's Car-Mart (CRMT)

GlobeNewswire

2 years ago

Inno Holdings Inc. Announces Closing of $10,000,000 Initial Public Offering

GlobeNewswire

2 years ago

Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results Posting Revenue Growth of 59% and Adjusted EBITDA Growth of 73%

ACCESSWIRE

2 years ago

INNO Holdings Launches Innovative Mobile Factory: Reinventing Construction Efficiency with Onsite Steel Framing Production

ACCESSWIRE

2 years ago

Inno Holdings Paves the Way for Sustainable Construction: Championing Green Building with Cold-Formed Steel

ACCESSWIRE

2 years ago

Inno Holdings Commences Trading on Nasdaq Capital Market

First Community Announces Leadership Moves

PR Newswire

2 years ago

First Community Announces Leadership Moves

Loop Media, Inc. (PNK:LPTV) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Loop Media, Inc. (PNK:LPTV) Q4 2023 Earnings Call Transcript

Modiv Industrial Declares Quarterly Dividends for Preferred Shareholders and Monthly Distributions for Common Shareholders

Business Wire

2 years ago

Modiv Industrial Declares Quarterly Dividends for Preferred Shareholders and Monthly Distributions for Common Shareholders

Shareholders in Crown Crafts (NASDAQ:CRWS) are in the red if they invested three years ago

Simply Wall St.

2 years ago

Shareholders in Crown Crafts (NASDAQ:CRWS) are in the red if they invested three years ago

Share on Social Networks: